Announcement
30 Sep 2024
In September 2024, US BARDA awarded a USD 21 million contract to Ossium Health to support a clinical trial of a bone marrow treatment for use in radiological or nuclear emergencies.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
30 Sep 2024
Revocation date:
No revocation date
Updated: 30 Sep 2024
State aid, unspecified
In force
On 30 September 2024, the Biomedical Advanced Research and Development Authority (BARDA) announced funding for Ossium Health to evaluate a bone marrow medical countermeasure. The contract supports ...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.